Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Crow

Showing results (681-690 of 1,180) with videos related to

Pageof 118
Sort By:
British Medical Journal (Clinical Research Ed.)|January 10, 1981
Reduced dopamine-beta-hydroxylase activity in Alzheimer's diseaseA J Cross, T J Crow, E K Perry, et al.
Journal of Clinical Psychopharmacology|October 1, 1982
Abnormal involuntary movements in schizophrenia: are they related to the disease process or its treatment? Are they associated with changes in dopamine receptors?T J Crow, A J Cross, E C Johnstone, et al.
Neuroimage|January 18, 2005
Automatic analysis of cerebral asymmetry: an exploratory study of the relationship between brain torque and planum temporale asymmetryThomas R Barrick, Clare E Mackay, Sylvain Prima, et al.
The International Journal of Eating Disorders|August 16, 2000
Cytokine production in patients with anorexia nervosa, bulimia nervosa, and obesityN C Raymond, M Dysken, K Bettin, et al.
Comprehensive Psychiatry|November 13, 2001
Differences in DSM-III-R and DSM-IV diagnoses in eating disorder patientsS R Sunday, C B Peterson, K Andreyka, et al.
Artificial Organs|August 1, 1982
Membrane effect on platelet function during hemodialysis: a comparison of cuprophan and polycarbonateN Sreeharan, M J Crow, M C Salter, et al.
Psychological Medicine|February 1, 1985
Lateral ventricular size in schizophrenia: relationship to the disease process and its clinical manifestationsD G Owens, E C Johnstone, T J Crow, et al.
Developmental Medicine and Child Neurology|August 20, 2021
Cerebrospinal fluid neopterin as a biomarker of treatment response to Janus kinase inhibition in Aicardi-Goutières syndromeVelda X Han, Shekeeb S Mohammad, Hannah F Jones, et al.
Brain : a Journal of Neurology|March 2, 1999
The size and fibre composition of the corpus callosum with respect to gender and schizophrenia: a post-mortem studyJ R Highley, M M Esiri, B McDonald, et al.
The International Journal of Eating Disorders|October 20, 2010
Weight suppression as a predictor variable in treatment trials of bulimia nervosa and binge eating disorderChristie Zunker, Ross D Crosby, James E Mitchell, et al.
Pageof 118

Showing results (681-690 of 1,180) with videos related to

Sort By:
Pageof 118
British Medical Journal (Clinical Research Ed.)|January 10, 1981
Reduced dopamine-beta-hydroxylase activity in Alzheimer's diseaseA J Cross, T J Crow, E K Perry, et al.
Journal of Clinical Psychopharmacology|October 1, 1982
Abnormal involuntary movements in schizophrenia: are they related to the disease process or its treatment? Are they associated with changes in dopamine receptors?T J Crow, A J Cross, E C Johnstone, et al.
Neuroimage|January 18, 2005
Automatic analysis of cerebral asymmetry: an exploratory study of the relationship between brain torque and planum temporale asymmetryThomas R Barrick, Clare E Mackay, Sylvain Prima, et al.
The International Journal of Eating Disorders|August 16, 2000
Cytokine production in patients with anorexia nervosa, bulimia nervosa, and obesityN C Raymond, M Dysken, K Bettin, et al.
Comprehensive Psychiatry|November 13, 2001
Differences in DSM-III-R and DSM-IV diagnoses in eating disorder patientsS R Sunday, C B Peterson, K Andreyka, et al.
Artificial Organs|August 1, 1982
Membrane effect on platelet function during hemodialysis: a comparison of cuprophan and polycarbonateN Sreeharan, M J Crow, M C Salter, et al.
Psychological Medicine|February 1, 1985
Lateral ventricular size in schizophrenia: relationship to the disease process and its clinical manifestationsD G Owens, E C Johnstone, T J Crow, et al.
Developmental Medicine and Child Neurology|August 20, 2021
Cerebrospinal fluid neopterin as a biomarker of treatment response to Janus kinase inhibition in Aicardi-Goutières syndromeVelda X Han, Shekeeb S Mohammad, Hannah F Jones, et al.
Brain : a Journal of Neurology|March 2, 1999
The size and fibre composition of the corpus callosum with respect to gender and schizophrenia: a post-mortem studyJ R Highley, M M Esiri, B McDonald, et al.
The International Journal of Eating Disorders|October 20, 2010
Weight suppression as a predictor variable in treatment trials of bulimia nervosa and binge eating disorderChristie Zunker, Ross D Crosby, James E Mitchell, et al.
Pageof 118